under its brand Sovaldi. On 11 March 2015, Natco Pharma announced that it is the first company in India to get approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General (India).

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,417.45 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development manufacturing and marketing of Finished Dosage Formulations (FDF) and Active ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

Cash Taxes Paid 286.30 177.50 48.20 130.00 ...

Competition page helps you compare Natco Pharma Ltd. with its sector peers on key parameters.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Disclosure under regulation 30 of the SEBI (LODR) Regulations, 2015 ...

Xiaomi also makes fitness trackers, TVs, air purifiers, and tablets. It has a skin for its Android phones and tablets – MIUI. The company largely sells its phones via flash sales in India. Xiaomi's ...

OnePlus is a Shenzhen-based start-up and producer of smartphones founded in December, 2013. The company's claim to fame is its bid to offer flagship-level specs in its smartphones, at affordable ...